US 10577607
Modulation of DYRK1B expression
granted A61KA61K31/7088A61K31/7115
Quick answer
US patent 10577607 (Modulation of DYRK1B expression) held by Ionis Pharmaceuticals, Inc. expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/7088, A61K31/7115, A61K31/712, A61K31/7125